Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer

20 Aug 2020

Abstract excerpt

Long-term use of platinum-based drugs can cause non-small cell lung cancer (NSCLC) to develop extremely strong drug resistance. Increasing the drug dosage does not have better treatment effects and could lead to serious complications. High levels of drug resistance are considered to be characteristic of human tumours and are usually mediated by genes related to multidrug resistance. Multidrug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA and Nucleic Acid Chemistry
Share to Drug Transport and Resistance Mechanisms
Share to Metal complexes synthesis and properties

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32815556
DOI: 10.1002/cbf.3577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancerPMID 32815556Read ↗

Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosisSemantic proximity Read ↗

Role of long non-coding RNA in drug resistance in non-small cell lung cancer.Semantic proximity Read ↗

miR-181b inhibits chemoresistance in cisplatin-resistant H446 small cell lung cancer cells by targeting Bcl-2Semantic proximity Read ↗

MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.Semantic proximity Read ↗

ABCC3 as a marker for multidrug resistance in non-small cell lung cancerSemantic proximity Read ↗

Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.Semantic proximity Read ↗

miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell linesSemantic proximity Read ↗

KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 CellsSemantic proximity Read ↗

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cellsSemantic proximity Read ↗

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancerSemantic proximity Read ↗

Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1‐ABCG2 signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.